TOWA Pharmaceutical Co (TSE:4553) 5-Year EBITDA Growth Rate : 7.60% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co 5-Year EBITDA Growth Rate?

TOWA Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円145.47.

During the past 12 months, TOWA Pharmaceutical Co's average EBITDA Per Share Growth Rate was 75.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 15.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of TOWA Pharmaceutical Co was 35.00% per year. The lowest was -6.20% per year. And the median was 15.40% per year.

Competitive Comparison of TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

TOWA Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

TOWA Pharmaceutical Co (TSE:4553) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

TOWA Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

TOWA Pharmaceutical Co (TSE:4553) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

6QC:Germany

Address

2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580

Website

http://www.towayakuhin.co.jp

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines